These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 16791478
1. Association of GSTP1 CpG islands hypermethylation with poor prognosis in human breast cancers. Arai T, Miyoshi Y, Kim SJ, Taguchi T, Tamaki Y, Noguchi S. Breast Cancer Res Treat; 2006 Nov; 100(2):169-76. PubMed ID: 16791478 [Abstract] [Full Text] [Related]
2. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy. Bastian PJ, Palapattu GS, Lin X, Yegnasubramanian S, Mangold LA, Trock B, Eisenberger MA, Partin AW, Nelson WG. Clin Cancer Res; 2005 Jun 01; 11(11):4037-43. PubMed ID: 15930338 [Abstract] [Full Text] [Related]
3. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients. Sharma G, Mirza S, Parshad R, Srivastava A, Gupta SD, Pandya P, Ralhan R. Life Sci; 2010 Jul 17; 87(3-4):83-91. PubMed ID: 20470789 [Abstract] [Full Text] [Related]
6. [Detection of aberrant promoter CpG islands hypermethylation of GSTP1 in human primary hepatocellular carcinomas]. Wang JH, Qin Y, Li B, Sun ZL, Sun ZF, Guan QL. Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep 17; 36(5):686-8. PubMed ID: 16235538 [Abstract] [Full Text] [Related]
9. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma. Nakamichi I, Tomita Y, Zhang B, Sugiyama H, Kanakura Y, Fukuhara S, Hino M, Kanamaru A, Ogawa H, Aozasa K. Ann Hematol; 2007 Aug 17; 86(8):557-64. PubMed ID: 17508213 [Abstract] [Full Text] [Related]
14. Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas. Kim J, Lee HS, Bae SI, Lee YM, Kim WH. Anticancer Res; 2005 Jan 01; 25(6B):4013-9. PubMed ID: 16309193 [Abstract] [Full Text] [Related]
15. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells. Song JZ, Stirzaker C, Harrison J, Melki JR, Clark SJ. Oncogene; 2002 Feb 07; 21(7):1048-61. PubMed ID: 11850822 [Abstract] [Full Text] [Related]
16. GSTP1 hypermethylation is associated with reduced protein expression, aggressive disease and prognosis in neuroblastoma. Gumy-Pause F, Pardo B, Khoshbeen-Boudal M, Ansari M, Gayet-Ageron A, Sappino AP, Attiyeh EF, Ozsahin H. Genes Chromosomes Cancer; 2012 Feb 07; 51(2):174-85. PubMed ID: 22045684 [Abstract] [Full Text] [Related]
17. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Esteller M, Corn PG, Urena JM, Gabrielson E, Baylin SB, Herman JG. Cancer Res; 1998 Oct 15; 58(20):4515-8. PubMed ID: 9788592 [Abstract] [Full Text] [Related]
19. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance. Reibenwein J, Pils D, Horak P, Tomicek B, Goldner G, Worel N, Elandt K, Krainer M. Prostate; 2007 Mar 01; 67(4):427-32. PubMed ID: 17192910 [Abstract] [Full Text] [Related]
20. Association of GSTP1 expression with resistance to docetaxel and paclitaxel in human breast cancers. Arai T, Miyoshi Y, Kim SJ, Akazawa K, Maruyama N, Taguchi T, Tamaki Y, Noguchi S. Eur J Surg Oncol; 2008 Jul 01; 34(7):734-8. PubMed ID: 17764884 [Abstract] [Full Text] [Related] Page: [Next] [New Search]